(Q43055175)

13 November 2017

Death switch for gene therapy: application to erythropoietin transgene expression (English)

1 reference

13 November 2017

0 references

1 reference

D S Souza

1

1 reference

13 November 2017

D M Spencer

2

1 reference

13 November 2017

T S I Salles

3

1 reference

13 November 2017

M A Salomão

4

1 reference

13 November 2017

E Payen

5

1 reference

13 November 2017

Y Beuzard

6

1 reference

13 November 2017

H F Carvalho

7

1 reference

13 November 2017

F F Costa

8

1 reference

13 November 2017

S T Olalla Saad

9

1 reference

13 November 2017

language of work or name

English

0 references

publication date

21 May 2010

1 reference

Brazilian Journal of Medical and Biological Research

13 November 2017

1 reference

13 November 2017

43

1 reference

13 November 2017

7

1 reference

13 November 2017

634-644

1 reference

Controlling signal transduction with synthetic ligands

13 November 2017

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2010007500046

Functional analysis of Fas signaling in vivo using synthetic inducers of dimerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2010007500046

Improved artificial death switches based on caspases and FADD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2010007500046

Ablation of microvessels in vivo upon dimerization of iCaspase-9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2010007500046

Synthetic activation of caspases: artificial death switches

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2010007500046

Pharmacologically regulated Fas-mediated death of adoptively transferred T cells in a nonhuman primate model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2010007500046

Conditional cell ablation by tight control of caspase-3 dimerization in transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2010007500046

Redesigning an FKBP-ligand interface to generate chemical dimerizers with novel specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2010007500046

An inducible caspase 9 safety switch for T-cell therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2010007500046

AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2010007500046

Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2010007500046

Clinical gene transfer studies for hemophilia A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2010007500046

Long-term outcome of treatment of anemia in MDS with erythropoietin and G-CSF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2010007500046

Long-term doxycycline-regulated secretion of erythropoietin by encapsulated myoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2010007500046

Erythropoietin gene therapy leads to autoimmune anemia in macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2010007500046

Continuous delivery of human and mouse erythropoietin in mice by genetically engineered polymer encapsulated myoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2010007500046

Improvement of mouse beta-thalassemia upon erythropoietin delivery by encapsulated myoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2010007500046

Dimeric erythropoietin fusion protein with enhanced erythropoietic activity in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2010007500046

Human erythropoietin gene therapy for patients with chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2010007500046

Long-term pharmacologically regulated expression of erythropoietin in primates following AAV-mediated gene transfer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2010007500046

Long-term reversal of chronic anemia using a hypoxia-regulated erythropoietin gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2010007500046

A modified tetracycline-regulated system provides autoregulatory, inducible gene expression in cultured cells and transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2010007500046

Myoblast transfer of human erythropoietin gene in a mouse model of renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2010007500046

Autoimmune anemia in macaques following erythropoietin gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2010007500046

Oxygen tension and a pharmacological switch in the regulation of transgene expression for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2010007500046

A gene therapy approach to regulated delivery of erythropoietin as a function of oxygen tension

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2010007500046

Lack of an immune response against the tetracycline-dependent transactivator correlates with long-term doxycycline-regulated transgene expression in nonhuman primates after intramuscular injection of recombinant adeno-associated virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2010007500046

Antiangiogenic gene therapy: disruption of neovascular networks mediated by inducible caspase-9 delivered with a transcriptionally targeted adenoviral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2010007500046

Pharmacologically regulated cell therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2010007500046

High-efficiency gene transfer into skeletal muscle mediated by electric pulses

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2010007500046

Improvement of mouse beta-thalassemia by electrotransfer of erythropoietin cDNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2010007500046

Gene Electrotransfer Results in a High-Level Transduction of Rat Skeletal Muscle and Corrects Anemia of Renal Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2010007500046

10.1590/S0100-879X2010007500046

21 January 2018

Identifiers

DOI

1 reference

13 November 2017

1 reference